ESMO 2018

Reimbursement of newly approved cancer drugs may take more than one year

News 21 October 2018 0

After the European Medicines Agency (EMA) approves a new cancer drug, reimbursement decisions by each country’s health authorities can take up to one year, with wide variations between countries. according to a study just presented [more]

Low-adherence to hormonal therapy among premenopausal early breast cancer patients

News 20 October 2018 0

“At one year from initiation of TAM, plasma measurements show that a substantial proportion of premenopausal patients are not adequately adherent to this treatment. Poorly-adherent patients could benefit from metabolic and pharmacogenetic investigations. Identification of [more]